Labetalol: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Labetalol. Educational only — not medical advice.
Reported adverse reactions
| Reaction | Highest frequency reported* |
|---|---|
| Dizziness (%) | 16% |
| Fatigue | 12% |
| Bradycardia | 12% |
| Dizziness | 11% |
| Nausea | 6% |
| Paresthesias | 5% |
| Dyspepsia | 3% |
| Nasal stuffiness | 3% |
| Impotence | 3% |
| Headache | 2% |
| Abdominal pain | 2% |
| Diarrhea | 2% |
| Drowsiness | 2% |
| Ejaculation failure | 2% |
| Dyspnea | 2% |
| Vertigo | 2% |
| Asthenia | 1% |
| Taste distortion | 1% |
| Edema | 1% |
| Postural hypotension | 1% |
*Highest percentage across placebo-controlled trial tables summarized in current labeling.
Labeled uses
Labetalol hydrochloride tablets, USP are indicated in the management of hypertension. Labetalol hydrochloride tablets, USP may be used alone or in combination with other antihypertensive agents, especially thiazide and loop diuretics.
Source: FDA labeling via NIH DailyMed (set 706a877b…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.